Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | Oct 10, 2024 | 1 | -$394K | 4 | Oct 11, 2024 | Chief Financial Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2024 | 2 | $0 | 4 | Mar 5, 2024 | Chief Financial Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Oct 9, 2023 | 2 | $0 | 4 | Oct 10, 2023 | Chief Financial Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Oct 9, 2023 | 0 | $0 | 3 | Oct 10, 2023 | Chief Financial Officer |
VIR | Vir Biotechnology, Inc. | Feb 23, 2023 | 1 | -$58.4K | 4 | Feb 24, 2023 | CFO |
VIR | Vir Biotechnology, Inc. | Feb 17, 2023 | 1 | -$61.3K | 4 | Feb 21, 2023 | CFO |
VIR | Vir Biotechnology, Inc. | Feb 22, 2022 | 2 | $0 | 4 | Feb 24, 2022 | CFO |
VIR | Vir Biotechnology, Inc. | Feb 17, 2022 | 1 | -$76.4K | 4 | Feb 22, 2022 | CFO |